Tags: Drug.

Sifalimumab is a human monoclonal antibody designed for the treatment of SLE dermatomyositis and polymyositis.Sifalimumab was developed by MedImmune.

ATC prefix
none
CAS number
1143503-67-6
FDA UNII code
XOY1YA7RMC

Loading...

This page contains content from the copyrighted Wikipedia article "Sifalimumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.